Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Guizhou Chanhen Chemical Corporation (002895.SZ)
Fuquan, CN
Guizhou Chanhen Chemical Corporation specializes in the manufacturing and distribution of phosphate-based products throughout China. Its comprehensive portfolio includes industrial-grade and food-grade phosphoric acids, as well as monocalcium phosphate for animal feed supplementation. The company further supplies flame-retardant ammonium phosphate and polyphosphate compounds, alongside phosphorus gypsum utilized in construction materials. Additionally, it offers a variety of fertilizers, such as ammonium polyphosphate, NPK blends, ammonium phosphate, monoammonium phosphate, and monopotassium phosphate. Founded in 2002, the corporation maintains its headquarters in Fuquan, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.19% | -1.54% | -8.81% | -8.62% | -7.51% | -3.96% | +48.88% | +57.68% | +249.65% | +247.92% | +247.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+41.0% ★ Q1'26: +22.1% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+28.8% ★ Q1'26: -13.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+0.8% Q1'26: -40.6% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+19.7% ★ Q1'26: +14.0% (vs Q1'25)
-
ROIC Chemicals: +3.4%+15.0% ★ Q1'26: +9.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+2.3% Q1'26: +8.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.20× ★ Q1'26: 2.22× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
2.53B
est: 2.48B (+2.0%)
|
3.45B
est: 3.56B (-3.1%)
|
4.32B
est: 3.57B (+21.0%)
|
5.91B
est: 5.46B (+8.2%)
|
8.33B
est: 7.66B (+8.7%)
|
9.66B
8.67B – 10.72B
+26.1% YoY
|
10.43B
9.40B – 11.58B
+8.0% YoY
|
11.44B
10.28B – 12.69B
+9.6% YoY
|
| EBITDA |
569.22M
est: 667.50M (-14.7%)
|
1.23B
est: 957.46M (+28.0%)
|
1.42B
est: 960.69M (+48.2%)
|
1.71B
est: 1.58B (+8.0%)
|
2.09B
est: 2.22B (-5.8%)
|
2.80B
2.52B – 3.11B
+26.1% YoY
|
3.03B
2.73B – 3.36B
+8.0% YoY
|
3.32B
2.98B – 3.68B
+9.6% YoY
|
| EBIT |
459.55M
est: 530.62M (-13.4%)
|
1.06B
est: 761.13M (+39.9%)
|
1.13B
est: 763.69M (+47.4%)
|
1.30B
est: 1.28B (+2.2%)
|
1.64B
est: 1.79B (-8.3%)
|
2.26B
2.03B – 2.51B
+26.1% YoY
|
2.44B
2.20B – 2.71B
+8.0% YoY
|
2.67B
2.40B – 2.97B
+9.6% YoY
|
| Net Income |
367.76M
est: 409.64M (-10.2%)
|
758.66M
est: 852.09M (-11.0%)
|
766.40M
est: 798.66M (-4.0%)
|
956.48M
est: 1.01B (-5.6%)
|
1.26B
est: 1.26B (-0.3%)
|
1.46B
1.27B – 1.59B
+15.4% YoY
|
1.72B
1.69B – 1.74B
+18.0% YoY
|
2.05B
1.78B – 2.34B
+19.0% YoY
|
| SGA |
142.65M
est: 180.99M (-21.2%)
|
264.68M
est: 259.61M (+2.0%)
|
300.82M
est: 260.49M (+15.5%)
|
326.87M
est: 304.33M (+7.4%)
|
171.53M
est: 427.13M (-59.8%)
|
538.63M
483.18M – 597.35M
+26.1% YoY
|
581.72M
523.90M – 645.38M
+8.0% YoY
|
637.76M
573.27M – 707.43M
+9.6% YoY
|
| EPS |
0.76
est: 0.73 (+4.3%)
|
1.54
est: 1.52 (+1.7%)
|
1.53
est: 1.42 (+7.7%)
|
1.76
est: 1.76 (+0.0%)
|
2.19
est: 2.20 (-0.3%)
|
2.53
2.20 – 2.76
+15.4% YoY
|
2.99
2.94 – 3.02
+18.0% YoY
|
3.56
3.09 – 4.06
+19.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 753.8K | 0.06% |
| 2 | Dimensional - Emerging Markets High Profitability ETF DEHP | 0.00% | 9.8K | 0.44% |
| 3 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 214.2K | 0.29% |
| 4 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 174.6K | 0.39% |
| 5 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 54.1K | 0.26% |
| 6 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 24.0K | 0.48% |
| 7 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 2.67M | 0.06% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 138.9K | 0.28% |
| 9 | Vanguard Total International Stock ETF VXUS | 0.00% | 3.06M | 0.05% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 24.3K | 0.10% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Guo Qin Lu | Accounting Supervisor | — | — |
| Haibin Wu | Vice Chairman & President | — | male |
| Haibo Zhang | Vice President & Director | — | male |
| Jiacai Wang | Vice President & Director | — | male |
| Li Jian | Secretary of the Board | — | male |
| Yonghui He | Chief Financial Officer | — | male |
| Zi Jun Li | Vice President & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002895.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
